Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
-$0.17 today
- Market cap
- $271.79M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
Volume 0.05M
Average 0.04M
TTRX Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Turn Therapeutics Inc.NASDAQ: TTRX
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets of $18.64M in Q1 FY2026
Q1 FY2026 total assets was $18.64M.
Context
- Total assets increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 12.16M USD
- Year-over-year change
- +493.6%
- 2-year CAGR
- +145.8%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.16M | +493.6% |
| FY2024 | 2024-12-31 | 2.05M | +1.8% |
| FY2023 | 2023-12-31 | 2.01M | — |
Total Assets vs competitors
How TTRX compares with its peers on the latest reported figures
- TTRX's Mar 2026 total assets of $18.64M is the 7th highest of the 9 companies compared; the peer median is $51.46M.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Mar 2026 | $272.13M | -21.6% | -15.3% | |
| Mar 2026 | $186.46M | -6.9% | -18.1% | |
| Mar 2026 | $173.33M | +83.8% | +93.7% | |
IRDOpus Genetics, Inc. | Mar 2026 | $66.79M | +38.7% | +0.8% |
| Mar 2026 | $36.14M | +53.8% | -1.4% | |
| Mar 2026 | $29.7M | +102.9% | +21.6% | |
TTRXTurn Therapeutics Inc. | Mar 2026 | $18.64M | — | — |
| Apr 2026 | $14.87M | -12.4% | -19.1% | |
| Mar 2026 | $10.51M | +281.9% | — | |
| Peer median (excluding TTRX) | $51.46M | +46.2% | -1.4% | |
Competitors are the stored peer set for TTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Turn Therapeutics Inc.
NASDAQ:TTRX
Intrinsic Alpha fair value
Locked
Current Price
$8.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.